Efficacy and safety of anti-PD-1 antibody SHR-1210 combined with apatinib in patients with advanced triple-negative breast cancer.

Liu, JQ; Jiang, ZF; Li, Q; Li, Y; Liu, Q; Song, EW

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):